{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:12:07Z","timestamp":1793949127520,"version":"4.8.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12879-014-0628-7","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T15:05:44Z","timestamp":1417014344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Review of the literature and individual patients\u2019 data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections"],"prefix":"10.1186","volume":"14","author":[{"given":"Kurt G","family":"Naber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiltrud","family":"Niggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"key":"628_CR1","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.eururo.2008.05.010","volume":"54","author":"KG Naber","year":"2008","unstructured":"Naber KG, Schito G, Botto H, Palou J, Mazzei T: Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008, 54: 1164-1178. 10.1016\/j.eururo.2008.05.010.","journal-title":"Eur Urol"},{"key":"628_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/jac\/46.suppl_1.15","volume":"46","author":"G Kahlmeter","year":"2000","unstructured":"Kahlmeter G: The ECO-Sens Projekt: a prospective, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens- interim report. J Antimicr Chem. 2000, 46: 15-22. 10.1093\/jac\/46.suppl_1.15.","journal-title":"J Antimicr Chem"},{"key":"628_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","volume":"39","author":"G Kahlmeter","year":"2012","unstructured":"Kahlmeter G, Od\u00e9n Poulsen H: Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO\u2022SENS study revisited. Int J Antimicr Agents. 2012, 39: 45-51. 10.1016\/j.ijantimicag.2011.09.013.","journal-title":"Int J Antimicr Agents"},{"key":"628_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijantimicag.2003.09.004","volume":"23","author":"FME Wagenlehner","year":"2004","unstructured":"Wagenlehner FME, Naber KG: Emergence of antibiotic resistance and prudent use of antibiotic therapy in nosocomially acquired urinary tract infections. Int J Antimicr Agents. 2004, 23: 24-29. 10.1016\/j.ijantimicag.2003.09.004.","journal-title":"Int J Antimicr Agents"},{"key":"628_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/clinids\/20.1.183","volume":"20","author":"JF Fisher","year":"1995","unstructured":"Fisher JF, Newman CL, Sobel JD: Yeast in the urine: solutions for a budding problem. Clin Infect Dis. 1995, 20: 183-189. 10.1093\/clinids\/20.1.183.","journal-title":"Clin Infect Dis"},{"key":"628_CR6","first-page":"350","volume":"19","author":"ZA Bukhary","year":"2008","unstructured":"Bukhary ZA: Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transpl. 2008, 19: 350-360.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"628_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","volume":"16","author":"OK Azap","year":"2010","unstructured":"Azap OK, Arslan H, Serefhanoglu K, Colakoglu S, Erdogan H, Timurkaynak F, Senger SS: Risk factors for extended-spectrum b-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010, 16: 147-151. 10.1111\/j.1469-0691.2009.02941.x.","journal-title":"Clin Microbiol Infect"},{"key":"628_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10156-010-0178-x","volume":"17","author":"S-J Lee","year":"2011","unstructured":"Lee S-J, Lee DS, Choe HS, Shim BS, Kim CS, Kim ME, Cho Y-H: Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean antimicrobial resistance monitoring system. J Infect Chemother. 2011, 17: 440-446. 10.1007\/s10156-010-0178-x.","journal-title":"J Infect Chemother"},{"key":"628_CR9","first-page":"791","volume":"32","author":"Z Tandogdu","year":"2013","unstructured":"Tandogdu Z, Cek M, Wagenlehner F, Naber K, Tenke P, van Ostrum E, Bjerklund Johansen T: Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study. World J Urol. 2013, 32: 791-801.","journal-title":"World J Urol"},{"key":"628_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/520427","volume":"29","author":"JW Warren","year":"1999","unstructured":"Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999, 29: 745-758. 10.1086\/520427.","journal-title":"Clin Infect Dis"},{"key":"628_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011, 52: 103-120. 10.1093\/cid\/ciq257.","journal-title":"Clin Infect Dis"},{"key":"628_CR12","unstructured":"Wagenlehner FME, Schmiemann G, Hoyme U, Fuenfstueck R, Hummers-Pradier E, Kaase M, Kniehl E, Selbach I, Sester U, Vahlensieck W, Watermann D, Naber KG: Epidmiology, diagnostics, therapy and management of uncomplicated bacterial community acquired urinary tract infections in adults. [] (visited 16 Nov 2014), [\n                    http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/043-044l_S3_Harnwegsinfektionen.pdf\n                    \n                  ]"},{"key":"628_CR13","unstructured":"Grabe M, Bjerklund Johansen TE, Botto H, Wullt B, Cek M, Naber KG, Pickard RS, Tenke P, Wagenlehner F: Guidelines on Urological Infections. Part 19. Arnhem, The Netherlands: European Association of Urology; 2014:1\u2013107. ISBN 978-90-79754-65-6 [] (visited 16 Nov 2014)., [\n                    http:\/\/www.uroweb.org\/gls\/pdf\/19%20Urological%20infections_LR.pdf\n                    \n                  ]"},{"key":"628_CR14","volume-title":"Pharmaceutical Substances. Syntheses, Patents Applications","author":"A Kleemann","year":"1999","unstructured":"Kleemann A, Engel J, Reichert D, Kutscher B: Pharmaceutical Substances. Syntheses, Patents Applications. 1999, Thieme, Stuttgart, New York"},{"key":"628_CR15","volume-title":"Martindale. The Complete Drug Reference","author":"SC Sweetman","year":"2004","unstructured":"Sweetman SC: Martindale. The Complete Drug Reference. 2004, Pharmaceutical Press, London, 34","edition":"34"},{"key":"628_CR16","unstructured":"Rosen Pharma: Summary of Product Characteristics (SPC) of Nitroxolin Forte [Article in German]. [] (visited 16 Nov 2014), [\n                    http:\/\/www.fachinfo.de\/suche\/fi\/009370\n                    \n                  ]"},{"key":"628_CR17","first-page":"959","volume":"54","author":"MR Jacobs","year":"1978","unstructured":"Jacobs MR, Robinson RG, Koornhof HJ: Antibacterial activity of nitroxoline and sulphamethizole alone and in combination in urinary tract infections. S Afr Med J. 1978, 54: 959-962.","journal-title":"S Afr Med J"},{"key":"628_CR18","first-page":"86","volume":"64","author":"P Bourlioux","year":"1988","unstructured":"Bourlioux P, Amgar A: Multicenter study of the resistance to seven antibiotics of pathogens recovered from urinary tract infections [Article in French]. Sem H\u00f4p Paris. 1988, 64: 86-90.","journal-title":"Sem H\u00f4p Paris"},{"key":"628_CR19","unstructured":"National Antibiotic Susceptibility Testing Committee (Germany): Nitroxoline. Rationale for the NAK Clinical Breakpoints. [ ] (visited 16 Nov 2014)., [\n                    http:\/\/www.nak-deutschland.org\/tl_files\/nak-deutschland\/Nitroxoline_rationale_V_1.0_31012014.pdf\n                    \n                  ]"},{"key":"628_CR20","first-page":"1001","volume":"34","author":"C Bonissol","year":"1966","unstructured":"Bonissol C, Pua K, Stoiljkovic B: In vitro activity of nitroxoline on urogenital mycoplasmas [Article in French]. Pathol Biol (Paris). 1966, 34: 1001-1005.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR21","first-page":"226","volume":"4","author":"A Amgar","year":"1989","unstructured":"Amgar A: Activity in vitro of urine samples from patients treated by nitroxoline against mycoplasmas. J Chemother. 1989, 4: 226-228.","journal-title":"J Chemother"},{"key":"628_CR22","first-page":"823","volume":"34","author":"JM Hern\u00e1ndez Molina","year":"1991","unstructured":"Hern\u00e1ndez Molina JM, Llos\u00e1 J, Ventosa A: In vitro activity of nitroxoline against clinical isolates of Candida species. Mycoses. 1991, 34: 823-825.","journal-title":"Mycoses"},{"key":"628_CR23","first-page":"26","volume":"18","author":"J Focht","year":"1995","unstructured":"Focht J, Noesner K: In-vitro activity of nitroxoline against Candida [Article in German]. Extracta Urologica. 1995, 18: 26-27.","journal-title":"Extracta Urologica"},{"key":"628_CR24","first-page":"669","volume":"35","author":"N Lambert-Zechovsky","year":"1987","unstructured":"Lambert-Zechovsky N, Leveque B, Bingen E, Pillion G, Chapelle J, Mathieu H: Clinical study and effect of nitroxoline on fecal flora in children [Article in French]. Pathol Biol (Paris). 1987, 35: 669-672.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR25","unstructured":"Kresken M, K\u00f6rber-Irrgang B, on behalf of the Working Party Antimicrobial Resistance of the Paul Ehrlich Society of Chemotherapy: In vitro activity of nitroxoline against urine isolates of Escherichia coli from the community: results of a German multicentre study [Abstract]. In 23rd European Congress of Clinical Microbiology and Infectious Diseases (23rd ECCMID): 27\u201330 April 2013; Berlin, Germany. [] (visited 16 Nov 2014), [\n                    http:\/\/registration.akm.ch\/einsicht.php?XNABSTRACT_ID=160328&XNSPRACHE_ID=2&XNKONGRESS_ID=180&XNMASKEN_ID=900\n                    \n                  ]"},{"key":"628_CR26","unstructured":"Kresken M, K\u00f6rber-Irrgang B: In vitro activity of nitroxoline against uropathogens other than Escherichia coli and impact of pH [Poster]. In 24th European Congress of Clinical Microbiology and Infectious Diseases (24th ECCMID): 10\u201313 May 2014; Barcelona, Spain. ,"},{"key":"628_CR27","first-page":"879","volume":"35","author":"B Cancet","year":"1987","unstructured":"Cancet B, Amgar A: In vitro antifungal activity of nitroxoline. Preliminary clinical results [Article in French]. Pathol Biol (Paris). 1987, 35: 879-881.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR28","first-page":"265","volume":"15","author":"A Michel-Nguyen","year":"1986","unstructured":"Michel-Nguyen A, Nourrit J, Penaud A, Nicoli RM: Nitroxoline and traditional antifungal agents. Comparison of their antifungal activity against 238 yeast strains [Article in French]. Bull Soc Fr Mycol Med. 1986, 15: 265-268.","journal-title":"Bull Soc Fr Mycol Med"},{"key":"628_CR29","first-page":"600","volume":"37","author":"P Bourlioux","year":"1989","unstructured":"Bourlioux P, Karam D, Amgar A, Perdiz M: Relationship between the chelating activity of nitroxoline, bacterial surface hydrophobicity and the reduction of bacterial adherence [Article in French]. Pathol Biol (Paris). 1989, 37: 600-604.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR30","first-page":"406","volume":"42","author":"C Pelletier","year":"1994","unstructured":"Pelletier C, Prognon P, Latrache H, Villart L, Bourlioux P: Microbiological effects of divalent metal ions interaction with nitroxoline [Article in French]. Pathol Biol (Paris). 1994, 42: 406-411.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1128\/AAC.39.3.707","volume":"39","author":"C Pelletier","year":"1995","unstructured":"Pelletier C, Prognon P, Bourlioux P: Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains. Antimicrob Agents Chemother. 1995, 39: 707-713. 10.1128\/AAC.39.3.707.","journal-title":"Antimicrob Agents Chemother"},{"key":"628_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/BF02818714","volume":"45","author":"H Latrache","year":"2000","unstructured":"Latrache H, Bourlioux P, Karroua M, Zahir H, Hakkou A: Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli. Folia Microbiol. 2000, 45: 485-490. 10.1007\/BF02818714.","journal-title":"Folia Microbiol"},{"key":"628_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1432-1033.1974.tb03597.x","volume":"46","author":"RSS Fraser","year":"1974","unstructured":"Fraser RSS, Creanor J: Rapid and selective inhibition of RNA synthesis in yeast by 8-hydroxyquinoline. Eur J Biochem. 1974, 46: 67-73. 10.1111\/j.1432-1033.1974.tb03597.x.","journal-title":"Eur J Biochem"},{"key":"628_CR34","first-page":"452","volume":"36","author":"D Karam","year":"1988","unstructured":"Karam D, Amgar A, Bourlioux P: Inhibition of bacterial adherence from uropathogenic Escherichia coli strains by the urine of patients treated by nitroxoline [Article in French]. Pathol Biol (Paris). 1988, 36: 452-455.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR35","first-page":"451","volume":"37","author":"P Bourlioux","year":"1889","unstructured":"Bourlioux P, Botto H, Karam D, Amgar A, Camey M: Reduction of bacterial adherence by nitroxoline on epithelial cells and on urinary catheter surfaces [Article in French]. Pathol Biol (Paris). 1889, 37: 451-454.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR36","first-page":"455","volume":"38","author":"L Oliviero","year":"1990","unstructured":"Oliviero L, Perdiz M, Bourlioux P: Direct effect of nitroxoline in the reduction of bacterial adherence on urinary catheter [Article in French]. Pathol Biol (Paris). 1990, 38: 455-458.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR37","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1128\/AAC.01484-12","volume":"56","author":"A Sobke","year":"2012","unstructured":"Sobke A, Klinger M, Hermann B, Sachse S, Nietzsche S, Makarewicz O, Keller PM, Straube PW: The urinary antibiotic 5-nitro-8-hydroxyquinoline (nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc. Antimicrob Agents Chemother. 2012, 56: 6021-6025. 10.1128\/AAC.01484-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"628_CR38","first-page":"873","volume":"35","author":"E Bergogne-Berezin","year":"1987","unstructured":"Bergogne-Berezin E, Berthelot G, Muller-Serieys C: Present status of nitroxoline [Article in French]. Pathol Biol (Paris). 1987, 35: 873-878.","journal-title":"Pathol Biol (Paris)"},{"key":"628_CR39","first-page":"476","volume":"17","author":"A Mrhar","year":"1979","unstructured":"Mrhar A, Kopitar Z, Kozjek F, Presl V, Karba R: Clinical pharmacokinetics of nitroxoline. Int J Clin Pharmacol Biopharm. 1979, 17: 476-481.","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"628_CR40","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/AAC.02147-13","volume":"58","author":"FME Wagenlehner","year":"2014","unstructured":"Wagenlehner FME, M\u00fcnch F, Pilatz A, B\u00e4rmann B, Weidner W, Wagenlehner CM, Straubinger M, Blenk H, Pfister W, Naber KG: Urinary antibacterial activity of Nitroxoline 250mg and Trimethoprim 200mg against uropathogens in healthy volunteers. Antimicrob Agents Chemother. 2014, 58: 713-721. 10.1128\/AAC.02147-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"628_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0378-4347(00)81056-7","volume":"222","author":"RH Sorel","year":"1981","unstructured":"Sorel RH, Snelleman C, Hulshoff A: High-performance liquid chromatographic analysis of nitoxoline in plasma and urine. J Chromatogr. 1981, 222: 241-248. 10.1016\/S0378-4347(00)81056-7.","journal-title":"J Chromatogr"},{"key":"628_CR42","first-page":"526","volume":"68","author":"M Franz","year":"1992","unstructured":"Franz M: The treatment of urinary tract infections with nitroxoline [Article in German]. Z Allg Med. 1992, 68: 526-530.","journal-title":"Z Allg Med"},{"key":"628_CR43","first-page":"1131","volume":"23","author":"R Kuss","year":"1962","unstructured":"Kuss R, Rometti A: Efficacy of 5-nitro-8-hydroxyquinoline (A82) in urinary tract infections [Article in French]. Extrait de la Presse M\u00e9dicale. 1962, 23: 1131-1132.","journal-title":"Extrait de la Presse M\u00e9dicale"},{"key":"628_CR44","first-page":"35","volume":"43","author":"L Moreau","year":"1962","unstructured":"Moreau L, Reveillaud R-J: A new urinary antifungal antibiotic [Article in French]. Essais Cliniques Du A. 82. Extrait de la Vie M\u00e9dicale. 1962, 43: 35-","journal-title":"Essais Cliniques Du A. 82. Extrait de la Vie M\u00e9dicale"},{"issue":"98","key":"628_CR45","first-page":"1864","volume":"47","author":"B von R\u00fctte","year":"1968","unstructured":"von R\u00fctte B, Delnon I: Experiences with drugs. Chronic urinary tract infection and its treatment with Nibiol [Article in German]. Schweiz Med Wochenschr. 1968, 47 (98): 1864-1868.","journal-title":"Schweiz Med Wochenschr"},{"key":"628_CR46","first-page":"1353","volume-title":"Advances in Antimicrobial and Antineoplastic Chemotherapy. Progress in Research and Clinical Application","author":"O Uhlir","year":"1972","unstructured":"Uhlir O, Hnatek J, Hatala M: Laboratory and clinical evaluation of 5-NOK. Advances in Antimicrobial and Antineoplastic Chemotherapy. Progress in Research and Clinical Application. Edited by: Hejzlar M, Semonsk\u00fd M, Mas\u00e1k S. 1972, 1353-1354."},{"key":"628_CR47","first-page":"439","volume":"4","author":"A Allal","year":"1973","unstructured":"Allal A, Giraud J-R, Kamina P, de Tourris H: Contribution to the treatment of urinary tract infections in pregnancy [Article in French]. L\u2019Ouest M\u00e9dical. 1973, 4: 439-444.","journal-title":"L\u2019Ouest M\u00e9dical"},{"issue":"3","key":"628_CR48","first-page":"183","volume":"10","author":"M Bittard","year":"1974","unstructured":"Bittard M, Colas J-M, Henry J-C: Current value of nitroxyquinoline in the treatment of urological infections [Article in French]. J de Besan\u00e7on. 1974, 10 (3): 183-188.","journal-title":"J de Besan\u00e7on"},{"issue":"6","key":"628_CR49","first-page":"429","volume":"68","author":"E Schlesinger","year":"1975","unstructured":"Schlesinger E, Patsch R, Kraft M: Initial experience with 5-nitrooxyquinoline in the treatment of chronic urinary tract infection [Article in German]. Zschr Urolog. 1975, 68 (6): 429-434.","journal-title":"Zschr Urolog"},{"issue":"23","key":"628_CR50","first-page":"1762","volume":"29","author":"J Aubert","year":"1976","unstructured":"Aubert J: Significance of anti-bacterial prevention with Nibiol forte during urological instrumentations [Article in French]. Ouest M\u00e9dical. 1976, 29 (23): 1762-1765.","journal-title":"Ouest M\u00e9dical"},{"key":"628_CR51","first-page":"207","volume":"3","author":"A Dufour","year":"1979","unstructured":"Dufour A, Bollack C: Penetration of nitroxoline into prostatic tissuea. A therapeutic trial [Article in French]. J Urol Nephrol. 1979, 3: 207-212.","journal-title":"J Urol Nephrol"},{"key":"628_CR52","first-page":"1735","volume":"33","author":"A Lenzner","year":"1983","unstructured":"Lenzner A: Oral treatment with nitroxoline for fungal complaints of urinary tract [Article in German]. Therapie Woche. 1983, 33: 1735-1738.","journal-title":"Therapie Woche"},{"issue":"25","key":"628_CR53","first-page":"1692","volume":"21","author":"J Sch\u00fclke","year":"1984","unstructured":"Sch\u00fclke J, S\u00f6keland J: Treatment of post operative urinary tract infection with Nitroxoline [Article in German]. Prakt Arzt. 1984, 21 (25): 1692-1696.","journal-title":"Prakt Arzt"},{"key":"628_CR54","first-page":"228","volume":"34","author":"D Sachse","year":"1984","unstructured":"Sachse D: Therapy for chronically-recurrent urinary tract infection with nitroxoline [Article in German]. Therapie Woche. 1984, 34: 228-230.","journal-title":"Therapie Woche"},{"issue":"2","key":"628_CR55","first-page":"307","volume":"XV","author":"D Demontrond","year":"1986","unstructured":"Demontrond D, Steinmetz P, Bernard PF: Treatment of 15 patients with nitroxoline for fungal urinary tract infections [Article in French]. Bull Soc Fr Mycol Med. 1986, XV (2): 307-310.","journal-title":"Bull Soc Fr Mycol Med"},{"issue":"17","key":"628_CR56","first-page":"71","volume":"94","author":"JL Frobert","year":"1987","unstructured":"Frobert JL, Coupry A: Nibiol forte in the treatment of uncomplicated lower urinary tract infections in women [Article in French]. Gazette M\u00e9dicale. 1987, 94 (17): 71-74.","journal-title":"Gazette M\u00e9dicale"},{"key":"628_CR57","first-page":"715","volume":"7","author":"M Lecornu","year":"1974","unstructured":"Lecornu M: The use of a suspension of nitroxoline for the treatment of pediatric urinary tract infections [Article in French]. Ouest M\u00e9dical. 1974, 7: 715-717.","journal-title":"Ouest M\u00e9dical"},{"key":"628_CR58","first-page":"85","volume":"2","author":"B Roussel","year":"1974","unstructured":"Roussel B, Dupouy D, Couchot J, Gomes H, Fandre M: Value of Nibiol suspension in the treatment of urinary tract infection in the infant and the child [Article in French]. J des M\u00e9decins du Nord de l\u2019Est. 1974, 2: 85-87.","journal-title":"J des M\u00e9decins du Nord de l\u2019Est"},{"key":"628_CR59","first-page":"59","volume":"567","author":"Raynaud","year":"1974","unstructured":"Raynaud : Nibiol suspension in pediatrics [Article in French]. M\u00e9decine Practicienne. 1974, 567: 59-60.","journal-title":"M\u00e9decine Practicienne"},{"key":"628_CR60","first-page":"545","volume":"6","author":"JC Luckel","year":"1975","unstructured":"Luckel JC, Brochard A, Juif JG: Value of Nibiol suspension in urinary tract infections in children [Article in French]. J M\u00e9d Strasbourg. 1975, 6: 545-548.","journal-title":"J M\u00e9d Strasbourg"},{"key":"628_CR61","first-page":"63","volume":"1","author":"C Viville","year":"1975","unstructured":"Viville C: Clinical trial of nitroxoline suspension [Article in French]. M\u00e9d G\u00e9n Med Nord. 1975, 1: 63-65.","journal-title":"M\u00e9d G\u00e9n Med Nord"},{"key":"628_CR62","first-page":"305","volume":"3","author":"JP Chable","year":"1975","unstructured":"Chable JP, Dumas R, Jean R: Nitroxoline in treatment of urinary tract infections in children [Article in French]. Bord Med. 1975, 3: 305-313.","journal-title":"Bord Med"},{"key":"628_CR63","first-page":"1597","volume":"13","author":"J Battin","year":"1975","unstructured":"Battin J: Use of nibiol suspension (nitroxoline) in pediatrics [Article in French]. Bord Med. 1975, 13: 1597-1600.","journal-title":"Bord Med"},{"key":"628_CR64","first-page":"49","volume":"2","author":"J Sorez","year":"1975","unstructured":"Sorez J, Vanlaeys R, Lelong M: Influence of a suspension of nitroxoline (Nibiol) in childhood urinary tract infections [Article in French]. Med Gen Med Nord. 1975, 2: 49-53.","journal-title":"Med Gen Med Nord"},{"key":"628_CR65","first-page":"90","volume":"1","author":"N Neimann","year":"1975","unstructured":"Neimann N, Andre JL: Clinical trial of Nibiol (nitroxoline) suspension in urinary infections in the infant and child [Article in French]. Med Gen Med Nord. 1975, 1: 90-96.","journal-title":"Med Gen Med Nord"},{"key":"628_CR66","first-page":"347","volume":"9","author":"D Machecourt","year":"1976","unstructured":"Machecourt D, Lebranchu Y, Bost M: Nitroxoline in treatment of urinary infections in children [Article in French]. RMAF. 1976, 9: 347-351.","journal-title":"RMAF"},{"issue":"42","key":"628_CR67","first-page":"4294","volume":"36","author":"J Sch\u00fclke","year":"1986","unstructured":"Sch\u00fclke J: Are gyrase inhibitors always better? [Article in German]. Therapie Woche. 1986, 36 (42): 4294-4297.","journal-title":"Therapie Woche"},{"issue":"29","key":"628_CR68","first-page":"56","volume":"95","author":"H Dodat","year":"1988","unstructured":"Dodat H, Chavrier Y, Dyon JF, Aubert D, Galifer RB, Montupet P, Morisson-Lacombe G, Moscovici J, Valla J: Multicenter clinical study of nitroxoline versus cotrimoxazole for prevention of urinary tract infection in children [Article in French]. Gazette M\u00e9dicale. 1988, 95 (29): 56-59.","journal-title":"Gazette M\u00e9dicale"},{"key":"628_CR69","unstructured":"WMA Declaration of Helsinki: Ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 41st WMA General Assembly, Hong Kong, September 1989. (visited 16 Nov 2014), [\n                    http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/index.html.pdf\n                    \n                  ]"},{"key":"628_CR70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0924-8579(99)00014-X","volume":"11","author":"KG Naber","year":"1999","unstructured":"Naber KG: Experience with the new guidelines on evaluation of new anti-infective drugs for the treatment of urinary tract infections. Int J Antimicrob Agents. 1999, 11: 189-196. 10.1016\/S0924-8579(99)00014-X. discussion 213\u2013216","journal-title":"Int J Antimicrob Agents"},{"key":"628_CR71","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","volume":"295","author":"G Piaggio","year":"2006","unstructured":"Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ: Reporting of noninferiority and equivalence randomized trials. An extension of the CONSORT statement. JAMA. 2006, 295: 1152-1160. 10.1001\/jama.295.10.1152.","journal-title":"JAMA"},{"key":"628_CR72","volume-title":"Multilevel and Longitudinal Modeling Using Stata","author":"S Rabe-Hesketh","year":"2012","unstructured":"Rabe-Hesketh S, Skrondal A: Multilevel and Longitudinal Modeling Using Stata. 2012, Stata Press, College Station, TX, 3","edition":"3"},{"key":"628_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical studies: is blinding necessary?. Contr Clin Trials. 1996, 17: 1-12. 10.1016\/0197-2456(95)00134-4.","journal-title":"Contr Clin Trials"},{"key":"628_CR74","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2036.2004.01878.x","volume":"19","author":"NS Abraham","year":"2004","unstructured":"Abraham NS, Moayyedi P, Daniels B, van Zanten JO: Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther. 2004, 19: 631-10.1111\/j.1365-2036.2004.01878.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"628_CR75","unstructured":"Cochrane Individual Participant Data (IPD) Meta-analysis Methods Group: About IPD meta-analyses. [] (visited 16 Nov 2014), [\n                    http:\/\/ipdmamg.cochrane.org\/about-ipd-meta-analyses\n                    \n                  ]"},{"key":"628_CR76","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0163278702025001006","volume":"25","author":"LA Stewart","year":"2002","unstructured":"Stewart LA, Tierney JF: To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof. 2002, 25: 76-97. 10.1177\/0163278702025001006.","journal-title":"Eval Health Prof"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0628-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0628-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:44:01Z","timestamp":1551167041000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0628-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0628-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]},"assertion":[{"value":"2 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"628"}}